Abstract:BackgroundPeptides have recently become attractive for therapeutic applications. However, efficient production of medium- to large-sized peptides (30–100 amino acids [aa]) remains challenging both by recombinant and chemical synthesis. We previously reported the formation of active enzyme aggregates in Escherichia coli cells induced by the short β-structured peptide ELK16 (LELELKLKLELELKLK) and developed a streamlined protein expression and purification approach. In this approach, a cleavable self-aggregating tag (cSAT) consisting of an intein molecule and ELK16 was used to release the recombinant peptides with reasonable purity from active aggregates.ResultsIn this work, we extended the cSAT approach to a generalized expression and purification solution for a set of medium- to large-sized peptides with important therapeutic uses, including human glucagon-like peptide 1 (31 aa), B-type natriuretic peptide (32 aa), exendin 4 (39 aa), chemokine (C–C motif) ligand 5 (also known as RANTES, 66 aa), stromal cell-derived factor 1α (67 aa), insulin-like growth factor 1 (70 aa), and leptin (146 aa). After intein-mediated cleavage, the soluble peptides were released directly into the supernatant while insoluble peptides could be refolded and purified by reverse phase high-performance liquid chromatography. Additionally, an N-terminal thioredoxin tag was added upstream of the target peptides, which can be removed by enterokinase cleavage, generating native N-terminus for target peptides. Final yields of the peptides ranged from 0.1 to 1.8 μg/mg wet cell weight at laboratory scale.ConclusionsThe approach described in this study provides a fast and efficient route to express and purify peptides that are difficult or expensive to produce by chemical synthesis or by ordinary recombinant methods. It is particularly well suited for large peptides, peptides likely to be degraded, and peptides that have toxic effects on the host. It can greatly reduce the cost and time of downstream processing, and thus may be useful for both industrial manufacture and laboratory applications.

Split Ssp DnaB Mini-Intein-mediated Production of Recombinant Human Glucagon-Like Peptide-1/7-36.

High cell density cultivation of recombinant Escherichia coli for prodrug of recombinant human GLPs production

Use of Ssp dnaB derived mini-intein as a fusion partner for production of recombinant human brain natriuretic peptide in Escherichia coli

One-Step Purification of a Fusion Protein of Glucagon-Like Peptide-1 and Human Serum Albumin Expressed in Pichia pastoris by an Immunomagnetic Separation Technique

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

Human Proinsulin C-Peptide from A Precursor Overexpressed in Pichia Pastoris

Expression of Human Globular Adiponectin-Glucagon-like Peptide-1 Analog Fusion Protein and Its Assay of Glucose-Lowering Effect in Vivo.

Production of Human Insulin in an E. Coli System with Met-Lys-human Proinsulin As the Expressed Precursor.

A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis.

Synthesis of the extracellular domain of GLP-1R by chemical and biotechnological approaches

Production of Human Proinsulin Ine. Coli in a Non-Fusion Form

Prepare and application of recombinant human pro-gastrin releasing peptide

Functional expression and purification of bovine enterokinase light chain in recombinant Escherichia coli.

[High Level Expression of Human Atrial Natriuretic Peptide in Fusion Form in E. Coli System].

Expression, purification, and characterization of the Degludec precursor DesB30

A pH-induced, intein-mediated expression and purification of recombinant human epidermal growth factor in Escherichia coli

Measurement of Recombinant Human Glucagon-Like Peptide-1 (7-36) Concentration by ELISA Kit Methods

Construction of Met-Lys-double-C peptide human proinsulin gene and its expression and characterization

A engineered Bifidobacterium longum secreting a bioative penetratin-Glucagon-like peptide 1 fusion protein enhances Glucagon-like peptide 1 absorption in the intestine.

Recombinant production of medium- to large-sized peptides in Escherichia coli using a cleavable self-aggregating tag

Cloning of CTB-PROIN fusion gene and its expression in Escherichia coli]